Shang Hai Zheng Quan Bao
Search documents
煤炭、有色、油气2026何去何从?
Shang Hai Zheng Quan Bao· 2026-02-05 00:55
公司与产经 07 |煤炭产业:基本面持续改善,价格中枢上移 有色市场 · 结构分化,波动加 煤炭产业:基本面持续改善,价格中枢上移 截至2月4日收盘,万得央企煤炭概念指数、万得煤炭开采精选指数涨幅分别达到7.61%和7.58%,中煤 能源、恒源煤电、充矿能源、山西焦煤、潞安环能、山煤国际、晋控煤业等一批个股涨停。煤炭企业人 士、研究员认为,短期内煤价或受印尼矿商暂停现货煤炭出口等消息的扰动。从中长期来看,煤炭供需 基本面有望持续改善,年度价格中枢有望上移。 2月3日,国家高端智库中国石油集团经济技术研究院发布最新预测:2026年,全球石油市场将在"供需 过剩现实"与"地缘冲突风险"之间动态博弈,布伦特油价中枢或维持在每桶60美元至 65美元;全球天然 气市场整体表现为需求增速回升、供应增量高于需求。 有色市场:结构分化,波动加剧 在2月3日中国有色金属工业协会举办的2025年有色金属工业经济运行情况新闻发布会上,协会相关负责 人表示,2025年全球主要有色金属价格整体呈现显著上行态势,我国规上有色金属工业企业利润总额创 历史新高。展望2026年,有色金属市场或有结构性分化,波动程度加剧,价格中枢或仍有上行潜力 ...
量产快、扩产忙、并购热 上市公司开年首月干劲足
Shang Hai Zheng Quan Bao· 2026-02-05 00:06
Core Insights - The article highlights the accelerated pace of institutional research on A-share listed companies as they release their 2025 performance forecasts, indicating a proactive approach to investment strategies for the new year [1] Group 1: Institutional Research Trends - Over 700 A-share listed companies have received institutional research since the beginning of the year, with over 20 companies attracting more than 100 institutions each [1] - Key sectors attracting attention include electronics, machinery, and pharmaceuticals, with power equipment and non-ferrous metals also being closely monitored [1] Group 2: New Product Launches - Several companies have announced accelerated timelines for new product mass production, showcasing confidence in growth for the new year [2] - Nepean Mining revealed plans to globally promote its innovative composite liner product in 2026, supported by the gradual production ramp-up of overseas facilities [2] - Huqin Technology's robotics division is set to deliver mass-produced robots in 2026, following significant advancements in R&D and project execution [2] - Jiemai Technology is investing in a production line for critical products, with mass production expected by mid-2026 [2] Group 3: Brain-Computer Interface Developments - Companies like Xiangyu Medical and Aipeng Medical are focusing on brain-computer interface technologies, with Xiangyu Medical planning to launch nearly 100 products by the end of 2026 [3] - The integration of software with rehabilitation equipment is expected to enhance product offerings and market competitiveness [3] Group 4: Industry Expansion and Growth - The demand for AI and computing power is driving growth in sectors like optical communication and liquid cooling, prompting companies to accelerate production capacity [4] - Daikin Heavy Industries reported a tight production schedule for overseas projects, anticipating significant growth in offshore wind energy markets [4] - Zhongji Xuchuang noted a strong order backlog extending into Q4 2026, indicating sustained high demand in the industry [4] Group 5: Storage and Liquid Cooling Innovations - Dike Technology plans to increase its storage chip output target to between 30 million and 50 million units in 2026, aiming to enhance revenue and net profit [5] - Dingtong Technology is expanding its liquid cooling production capabilities to meet rising customer demand [5] - Haitai Ruisheng is building a second overseas delivery base in Southeast Asia, expected to support significant orders from major tech clients [5] Group 6: Mergers and Acquisitions - Companies are increasingly pursuing mergers and acquisitions to enter new markets and drive growth [6] - Yingtang Zhikong plans to acquire Guanglong Integration and Aojian Microelectronics to enter the optical communication sector [6] - Dinglong Co. is acquiring Haofei New Materials to tap into the lithium battery functional materials market, with expected sales growth in 2026 [6] Group 7: Strategic Investments - Tianlu Technology is reallocating funds to projects aimed at enhancing its product offerings in the display industry, with equipment for the TAC film project expected to be operational by mid-2026 [7]
上证早知道|股票型ETF重现净流入;IC载板全球龙头拟扩产;“华龙一号”批量造
Shang Hai Zheng Quan Bao· 2026-02-04 23:16
Group 1 - The Ministry of Commerce will hold a press conference on February 5 to introduce key work in the business sector [2] - The global energy internet development cooperation organization will release the "Global Wind, Solar, and Hydropower Capacity Annual Forecast 2026" report on February 5 [2] - A total of 354 billion yuan in 7-day reverse repos will mature on February 5 [2] Group 2 - The 2026 Credit Market Work Conference emphasized support for expanding domestic demand, technological innovation, and small and medium-sized enterprises [4] - The State Administration for Market Regulation released 32 national metrology technical specifications, covering various fields including smart connected vehicles and health [4] - The Ministry of Culture and Tourism announced the resumption of travel for Shanghai residents to Kinmen and Matsu [4] Group 3 - Ibiden, a leading Japanese IC substrate manufacturer, announced a 500 billion yen (approximately 22.2 billion yuan) investment plan to expand high-performance IC substrate capacity from FY2026 to FY2028 [6] - The demand for IC substrates is increasing due to advancements in packaging technology, such as Chiplet packaging [6] - Chongda Technology announced a 1 billion yuan investment in a functional IC packaging substrate project in Jiangsu Province [6] Group 4 - The successful installation of the dome for the Zhangzhou Nuclear Power Unit 3 marks a significant milestone in the construction of the "Hualong One" nuclear power technology [8] - There are currently 41 units of "Hualong One" under construction or in operation, making it the most widely used nuclear power technology globally [9] - The World Nuclear Association projects that global nuclear power capacity could reach 1,446 GWe by 2050, surpassing the target set in the "Threefold Nuclear Energy Declaration" [9] Group 5 - The first brain-machine interface equipment for traditional Chinese medicine has been launched, aimed at patients with neurological injuries [10] - The technology is expected to revolutionize human-machine interaction, initially focusing on medical rehabilitation [10] - Companies like Weisi Medical and Innovation Medical are actively involved in the development of brain-machine interface technologies [10] Group 6 - Hengtong Optic-Electric has completed the construction of its AI advanced optical fiber materials R&D center and has entered the equipment installation phase [12] - Ruixin Technology is planning a major asset restructuring involving the acquisition of Wuhu Deheng Automotive Equipment Co., with stock suspension starting February 5 [12] - Changan Automobile plans to repurchase shares worth between 1 billion to 2 billion yuan to reduce registered capital [12] Group 7 - Shengxin Lithium Energy's subsidiary plans to acquire a 13.93% stake in Huirong Mining for 1.26 billion yuan, aiming for full control [13] - Sileck's subsidiary received a project confirmation letter from a South Korean battery client for cylindrical battery shell products, with an expected total procurement of approximately 360 million units [13] - Huibo Technology signed a contract worth 225 million USD (approximately 1.596 billion yuan) for the Naft Khana oilfield restoration project in Iraq [13] Group 8 - On February 3, stock-type ETFs (excluding cross-border ETFs) saw a net inflow of 6.965 billion yuan, marking a return to net inflows after a period of outflows [15] - The Southern CSI 500 ETF had a net inflow of 3.566 billion yuan, with several other ETFs also attracting significant investments [15] - The total scale of the Jiashi CSI 300 ETF has returned to over 100 billion yuan, reaching 100.824 billion yuan [15] Group 9 - JinkoSolar received a net buy of 104 million yuan from institutional seats, representing 2.52% of total trading volume [16] - The company signed a strategic cooperation agreement with Jintai Technology to jointly develop AI-based high-throughput perovskite tandem solar cells [16] - The expected mass production of perovskite tandem cells could significantly enhance efficiency and application in various scenarios [16] Group 10 - Honghe Technology received a net buy of 95.766 million yuan from institutional seats, accounting for 5.26% of total trading volume [17] - The company is a leading manufacturer of high-end electronic fabrics, benefiting from strong demand in AI-related applications [17] - Other companies such as Jingsheng Mechanical and China International Marine also saw net buys from institutional investors [17]
603266 重大资产重组引来二次问询
Shang Hai Zheng Quan Bao· 2026-02-04 23:14
2月4日晚,天龙股份(603266)发布公告称,收到上海证券交易所下发的关于对资产收购事项的二次问 询函。二次问询重点聚焦上市公司投资收益可实现性、收入预测、内幕信息管理等问题。 回溯来看,1月5日,天龙股份宣布拟以现金方式合计出资2.32亿元,通过"股权受让+增资"一揽子交 易,取得苏州豪米波技术有限公司(下称"苏州豪米波")54.87%的股权,实现对后者的控股并将其纳入 合并报表范围。此举标志着公司加速向智能驾驶核心感知系统领域纵深布局,培育第二增长曲线。 二次问询聚焦四大问题 上交所在二次问询中提出,公司此前披露的监管回复经事后审核后仍有事项需进一步说明,问询重点围 绕四方面展开,包括交易合理性、乐观业绩预测、外部投资者退出安排及可能的内幕信息管理等问题。 首先,问询函对此次收购的合理性提出关注。 具体来看,本次交易完成后,苏州豪米波短期内仍处于亏损状态,将导致天龙股份未来2—3年业绩下 滑。同时,本次交易采用收益法评估结果35470万元作为定价依据,与苏州豪米波截至2025年9月30 日-1957.23万元的净资产相比估值溢价较高,且存在商誉减值、业绩承诺无法实现、业绩补偿不足等多 项风险。 因此,上 ...
上海海立(集团)股份有限公司第十届董事会第十七次会议决议公告

Shang Hai Zheng Quan Bao· 2026-02-04 20:02
Core Viewpoint - The company has appointed Zhu Haoli as the new deputy general manager following the departure of Cui Rongsheng due to organizational adjustments, with the decision made unanimously by the board of directors [1][4]. Group 1 - The board meeting was conducted via communication means, with all 9 directors present and the meeting procedures compliant with legal regulations and the company's articles of association [1]. - The board expressed gratitude for the contributions made by Cui Rongsheng during his tenure [3]. - The voting results for the appointment were 9 votes in favor, with no abstentions or opposition [4]. Group 2 - Zhu Haoli, born in October 1973, holds a master's degree in engineering and is a senior engineer with a background in various leadership roles within the industry [6]. - Zhu Haoli currently holds 66,700 shares of the company and meets all qualifications required for senior management positions as per relevant regulations [6].
内蒙古金煤化工科技股份有限公司关于控股股东部分股份质押的公告

Shang Hai Zheng Quan Bao· 2026-02-04 20:02
证券代码:600844,900921 证券简称:金煤科技,金煤B股编号:临2026-004 内蒙古金煤化工科技股份有限公司 关于控股股东部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 1.本次股份质押基本情况 ■ 注:尾数差额为四舍五入所致。 公司控股子公司江苏金聚合金材料有限公司向江苏丹阳农村商业银行股份有限公司申请300万元流动资 金贷款、公司控股子公司江苏金煤化工有限公司向江苏张家港农村商业银行股份有限公司丹阳支行申请 400万元流动资金贷款,均由丹阳市同创融资担保有限公司(简称:丹阳同创)提供担保,金睿泓吉分 别将其持有的220万股、290万股公司A股股份质押给丹阳同创,用于丹阳同创向公司提供担保的反担 保,以支持公司的生产经营活动。 2.拟质押股份未被用作重大资产重组业绩补偿等事项的担保或其他保障用途。 二、累计质押股份情况 截至公告披露日,上述股东及其一致行动人累计质押股份情况如下: 重要内容提示: ● 公司控股股东内蒙古金睿泓吉企业管理有限责任公司现持有公司15,250万股A股股份,占公 ...
广州维力医疗器械股份有限公司关于公司产品获得欧盟MDR认证的公告
Shang Hai Zheng Quan Bao· 2026-02-04 20:00
广州维力医疗器械股份有限公司 关于公司产品获得欧盟MDR认证的公告 证券代码:603309 证券简称:维力医疗 公告编号:2026-008 三、风险提示 上述产品在相关海外市场的实际销售情况取决于未来市场的推广效果,目前尚无法预测此次获得认证对 公司未来经营业绩的具体影响。敬请投资者注意投资风险。 特此公告。 广州维力医疗器械股份有限公司 董事会 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 广州维力医疗器械股份有限公司(以下简称"公司")于近日收到欧盟公告机构通知,公司欧盟医疗器械 法规(Medical Device REGULATION (EU) 2017/745,简称"MDR")认证证书中新增了多个产品的欧盟 MDR认证,现将有关情况公告如下: 一、MDR认证证书的具体情况 ■■ 二、对公司的影响 上述产品获得欧盟MDR认证,表明其符合欧盟最新医疗器械法规要求,具备欧盟市场的最新准入条 件,可以在相关海外市场合法销售,对公司产品在相应市场的推广和销售起到推动作用。 2026年2月5日 ...
龙迅半导体(合肥)股份有限公司2024年限制性股票激励计划部分第一类限制性股票回购注销实施公告
Shang Hai Zheng Quan Bao· 2026-02-04 20:00
Core Viewpoint - Longxin Semiconductor (Hefei) Co., Ltd. is implementing a buyback and cancellation of 286 shares of the first category of restricted stock due to not meeting performance targets for the 2024 stock incentive plan [2][5]. Group 1: Buyback and Cancellation Details - The buyback and cancellation of restricted stock is based on the company's failure to meet the performance threshold set for 2024, as per the relevant regulations [2][5]. - The decision for the buyback was approved during the board meetings held on November 21, 2025, and subsequently at the shareholders' meeting on December 8, 2025, with a buyback price set at 35.27 yuan per share [3][4]. - The company has opened a dedicated securities account for the buyback and plans to complete the cancellation by February 9, 2026 [6]. Group 2: Performance Metrics - In 2024, the company reported a gross margin of 55.48% and revenue of 466 million yuan, which represented a 44.21% increase from 2023, but did not meet the performance target required for the release of the restricted stock [5][6]. - The proportion of restricted stock that could be released based on the company's performance was 91.73%, indicating that a significant portion did not meet the necessary criteria for release [6]. Group 3: Legal and Compliance - The company has complied with the necessary legal procedures and disclosed information regarding the buyback, ensuring that the rights of the incentive recipients and creditors are not harmed [4][8]. - Legal opinions confirm that the buyback and cancellation process adheres to the Company Law, the Management Measures for Equity Incentives, and the company's articles of association [8].
广州洁特生物过滤股份有限公司关于公司诉讼事项重审一审判决的进展公告
Shang Hai Zheng Quan Bao· 2026-02-04 20:00
Core Viewpoint - The company is currently involved in a legal dispute with Shenzhen Hosheng Medical Technology Co., Ltd. regarding a mold procurement contract, with a total claim amount of 10,340,829 yuan and additional losses of 644,911 yuan [2][3]. Group 1: Litigation Status - The case is at the stage of retrial in the first instance [2]. - The company is the plaintiff (and counter-defendant) in this litigation [2]. - The company has previously fully provided for bad debts related to the advance payment to Hosheng Medical [2][5]. Group 2: Background of the Litigation - The company filed a lawsuit against Hosheng Medical in August 2022 due to disputes over nine mold procurement contracts signed between November 2020 and January 2021 [3]. - In March 2023, the Huangpu Court ruled to terminate the contracts and ordered Hosheng Medical to refund the payment and compensate for losses, but Hosheng Medical appealed the decision [3]. - In March 2024, the Guangzhou Intermediate People's Court annulled the original ruling and sent the case back for retrial [3]. Group 3: Retrial Judgment - The Huangpu Court recently issued a civil judgment, which includes the termination of the contracts and rejection of the company's other claims, while also dismissing all claims from Hosheng Medical [4]. - The company is responsible for the litigation costs amounting to 87,131.24 yuan for the main case and 5,000 yuan for litigation preservation [4]. Group 4: Future Implications - The company plans to appeal the recent judgment, but it is currently unable to estimate the impact on its profits for the current and future periods [5]. - The company will continue to monitor the case's progress and fulfill its information disclosure obligations [5].
上海浦东建设股份有限公司2026年第一次临时股东会决议公告
Shang Hai Zheng Quan Bao· 2026-02-04 20:00
2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 本次会议是否有否决议案:无 一、会议召开和出席情况 (一)股东会召开的时间:2026年2月4日 (二)股东会召开的地点:上海市浦东新区成山路718弄1号TOP芯联T1座三楼路演厅 证券代码:600284 证券简称:浦东建设 公告编号:临2026-007 上海浦东建设股份有限公司 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: ■ (四)表决方式是否符合《公司法》及《公司章程》的规定,会议主持情况等。 本次会议由公司董事会召集,现场会议由公司董事长赵炜诚先生主持。会议采用现场投票和网络投票相 结合的表决方式。本次会议的召集、召开及表决方式均符合《公司法》《上海证券交易所股票上市规 则》《上市公司股东会规则》《公司章程》及公司《股东会议事规则》等有关规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事8人,出席6人,董事马成先生、杨卫东先生因日程安排冲突未能出席; 2、公司副总经理黄微先生、董事会 ...